"Left ventricular dyssynchrony is associated with reduced heart rate variability in familial amyloidotic polyneuropathy" International Journal of Cardiology, 155 (2) Methods: Twenty-nine FAP patients and 29 healthy controls were studied using Doppler echocardiography. Patients' and controls' HRV was studied using power spectral analysis from 24-hour Holter ECG recordings.
Introduction
Familial amyloidotic polyneuropathy (FAP) is a rare hereditary disorder which is caused by mutated transthyretin (TTR) [1] . Among the over 100 documented amyloid TTR mutations [2] , the most common mutation is the exchange of valine for methionine at position 30 (ATTR Val30Met), which is often found in endemic areas in Portugal, Japan, and Sweden. The typical symptom of FAP is peripheral sensori-motor polyneuropathy, often accompanied by autonomic neuropathy that causes a defective autoregulation of lood pressure and heart rate [3] . b
Cardiac complications, e.g. arrhythmia, are described in FAP patients who develop increased left ventricular (LV) wall thickness, diastolic dysfunction and enlarged atria [4] , [5] . FAP patients develop autonomic system dysfunction during the disease process which is progressive in nature. This can easily be assessed by heart rate variability (HRV) studies [4] , [5] , [6] . Although autonomic disturbances are a well-established mechanism for reduced HRV [7] , we hypothesize that cardiac function disturbances by themselves may have an additional impact on HRV -in a way similar to what was previously found in dilated cardiomyopathy [8] [9] . The aim of this study was, therefore, to assess the elationship between LV function and HRV in a cohort of Swedish patients with FAP. r
Methods

Study population
Thirty-five consecutive FAP patients were evaluated at Umeå University Hospital, Sweden. Twenty-four hour Holter-ECG recordings and Doppler echocardiographic studies were performed within 3 days of each other. Six patients were excluded because of poor quality of the ECG recordings. Of the studied FAP cohort, 29 patients (mean age 60.3±12.5 year, 12 female) constituted the study population, five of whom had prior liver transplantation. All patients proved to be carriers of the ATTR Val30Met trait and the diagnosis of FAP was histopathologically confirmed in all, based on biopsy evidence for amyloid deposits in the skin or intestine. One patient was on β-blockers for hypertension. All patients were managed according to the Declaration of Helsinki. All examinations were performed as part of their clinical evaluation before and after liver transplantation, as well as for diagnosis and identification of complications of the disease. The control group consisted of twenty-nine sex and age-matched healthy subjects (age 55.2±11.2 year, 13 female) selected from the Swedish population registry, none of whom had any cardiac or systemic disease. All patients and controls gave informed consent to participate in the study, which was approved by the Local Ethics Committee of Umeå University. Patients were followed up for 1.1-7.1 years, average 4.5 ± 2.2 years. At the end of the follow up period, cardiac events were documented including: cardiac death, hospital admission with uncontrolled heart failure symptoms r pacemaker implantation. o
Echocardiography
Echocardigraphy was performed using a Vivid 7 digital ultrasound system (GE Vingmed Ultrasound, Horten, Norway) equipped with a phased array transducer (1.5-4 MHz), and standard Doppler echocardiography was obtained as well as myocardial tissue pulsed Doppler imaging (TDI). The echocardiographic examination was performed with the subject in the left lateral decubitus position and recordings were made during quiet expiration. Parasternal and apical projections were studied according to the recommendations of the American Society of Echocardiography [10] . All recordings were made with a simultaneously superimposed electrocardiogram (ECG) [11] and at a sweep speed of 100 mm/s.
Echocardiographic measurements
The following M-mode echocardiographic measurements were made: LV internal diameter (LVd), septal (IVS) thickness, and posterior wall (PW) thickness, all measured at end-diastole (onset of the Q wave of the ECG), using leading edge methodology. End systolic dimension (LVs) was also measured as the shortest distance between septal and posterior wall endocardial border, and LV fractional shortening (LVFS) was calculated as the percentage fall in cavity dimension during systole with respect to that at enddiastole [12] . LV long-axis M-mode recordings were obtained with the cursor placed at the lateral and septal angles of the mitral annulus from the apical four-chamber view. LV long-axis amplitude of motion was measured as the distance between the innermost point and outermost point of the motion display. Left atrial dimension (LAd) was measured at end-systole. The stroke volume (SV) was calculated from the LV outflow tract cross sectional area (LV outflow tract radius 2 ×π) multiplied by blood flow velocity ime integral (VTI). t Conventional diastolic LV function was assessed from the filling pattern. Peak LV early (E) and late (A) filling velocities were measured from the pulsed wave Doppler recordings of the transmitral forward flow and E/A ratio was calculated [13] . E wave deceleration time (DT) was measured from the time of peak velocity to the point when left atrial and left ventricular pressures equalised. LV filling time (FT) was measured as the time interval between the onset of the E wave and the end of A wave. LV ejection time was taken from the onset to the end of aortic flow velocity signal. Relative ejection and filling times with respect to R-R interval were calculated and expressed as (%). In addition, they were both multiplied (in seconds) by heart rate and then expressed as total ejection and filling times (s/min). From these measurements global dyssynchronous LV function was assessed using the following parameters: a) total isovolumic time (t-IVT), calculated as 60-[total ejection time + total filling time] and was expressed in s/min [14] ; and b) Tei index, calculated as the ratio between IVT and ejection time [15] , [16] . Finally, E/Em (a marker of LV filling pressure) was also measured, where Em was the peak early diastolic myocardial velocity at the basal septal egment obtained from the apical 4 chamber view [17] . s
HRV recordings
Ambulatory 24hour HRV recording
A continuous ECG was recorded during a 24-hour period using a two-channel ambulatory Holter recorder (Braemar DL 700, Braemar Inc., Burnsville, MN). The ECG data were digitized with a sampling rate of 128 Hz and analyzed using the Aspect Holter System (GE Healthcare, Borlänge, Sweden). Pathological events were automatically detected, which were then manually edited and confirmed. Conventional methods of Holter analysis were performed to determine the underlying rhythm, presence and frequency of atrial and ventricular extra beats, couplets, episodes of tachycardia, atrioventricular block, left or right bundle-branch block, sino-atrial block or arrest. Supraventricular tachycardia (SVT) was defined as a series of more than five consecutive supra-ventricular beats at a heart rate more than 100 beat/minute. Ventricular arrhythmia was defined as more than two consecutive ventricular beats at a heart rate less than 100 beat/minute and/or more than 10 ventricular beat/hour. Ventricular tachycardia was defined as three or more ventricular beats with a rate more than 100 beats/minute [18] .
Power spectra analysis of HRV
R-R intervals and the classification of heart beats were exported from the Holter software for further analyses using Matlab (Mathworks Inc., Natick, Mass., USA) as previously described [19] . Before HRV was analyzed, undetected ectopic beats were removed by additional filtering, where R-R intervals were removed if they differed more than 30% from the mean of the preceding and following RR intervals. Power spectrum analysis was performed using fast Fourier transformation (FFT) of N-N interval data.
Data from the 24-hour recording were divided in 300-second segments, and averaged spectra were calculated using the Welch method [19] . Each data segment was preprocessed by removal of the mean value and eventual linear trends in the series of R-R intervals. Data were then converted to a time series by cubic spline interpolation, followed by re-sampling at two Hz. Finally, data were smoothed using a Bartlettwindow before calculating the 2048-point FFT. Ectopic beats and episodes with poor signal quality were replaced by interpolation, but segments with more than 4% interpolated data were discarded. The percentage of segments used for frequency domain HRV analysis was used as an indicator of the quality of the recording and the 
12 lead Electrocardiogram (ECG)
Standard 12 lead resting ECG was recorded and analyzed using the GE Mac 5000 instrument (General Electric, Milwaukee, USA). The QRS duration, PR interval and QRS+PR interval were measured using the built-in software.
Statistical analyses
Statistical analysis was performed using SPSS 13.0 (SPSS, Chicago, IL, USA) was used.
All data were presented as mean ± SD. 
Results
Patients had higher heart rate (HR) as compared to controls (76.1 ± 12.5 vs. 64.3±7.6 pm, p<0.05). b
LV structure and function (Table 1)
In FAP patients, IVS and PW were thicker (p<0.01 for both). LV systolic function, assessed by LVFS, was maintained despite the smaller LV end-diastolic dimension (p=0.01). LV septal and lateral long axis amplitude of motion were not different from ontrols, neither was LAd. SV was maintained in patients. 
ECG and HRV vs. LV function
All patients and controls were in sinus rhythm. Fourteen (48%) patients had abnormal findings in the Holter-ECG recordings, commonly shown as various combinations of recurrent supra and ventricular ectopic beats (n=8), but only one patient had recurrent non-sustained ventricular tachycardia. Patients also had various degrees of electrical blocks varying between first and second degree AV-block, sino-atrial block and bundle branch block (n=2). Only one patient had non-conducted supra-ventricular beats for a aximum of 2.4 seconds. m
Patients' HRV parameters (PTOT, PVLF, PLF, PHF) were all lower than in controls (p<0.01 for all). Spectral analysis showed reduced total HRV (PTOT<300 ms 2 ) in 9/29 (31%) patients. Both FT/RR and t-IVT modestly correlated with HRV spectral parameters in patients (p<0.05 for all), whereas controls only presented a significant correlation between FT/RR and PVLF (Table 2 ). There was no relationship between HRV indices and the rest of the systolic and diastolic LV function measurements in the two roups. g
Reduced HRV and LV function
The relationship between HRV and LV function was further studied by dividing the patients in two subgroups: a) patients with reduced HRV, defined as PTOT<300 ms 2 (9 patients); and b) patients with relatively preserved HRV, defined as PTOT>300 ms 2 (n=20) (Fig 1) . This limit was selected because it is difficult to distinguish any low-and high-frequency peaks in the power spectrum when total HRV becomes lower than 300 ms 2 . As shown in Table 3 , LV size and systolic function were not different between the two subgroups, but long axis amplitude of motion was significantly lower in patients with reduced HRV (Septal: p<0.01 and Lateral: p<0.05, respectively), as compared to those without reduced HRV. Patients with reduced HRV also had shorter FT/RR (p<0.01), longer t-IVT (p<0.01), higher Tei index (p=0.05), higher A wave (p<0.01) and higher E/Em (p<0.05), as compared to patients without reduced HRV. E/A was not different between groups (p=ns). T-IVT correlated with SV in the two subgroups (r=-0.80, p<0.01 and r=-0.41, p<0.05), but to a much stronger extent in those with reduced RV (Fig 2) . H
Clinical outcome
During the follow-up period (4.5 ± 2.2 years), 8 of 29 patients had cardiac events: two patients died; three patients developed significantly thickened LV and RV walls (two of them required pacemakers); two patients received pacemaker treatment because of cardiac conduction disturbances; and the remaining patient developed heart failure.
Four of these 8 patients were in the subgroup with reduced HRV (2 died and 2 received pacemakers). The incidence of cardiac events was significantly different in the two ubgroups (p<0.05). s
12 lead ECG in the two subgroups of patients
There was no difference between reduced HRV and preserved HRV subgroup in QRS (97±17 ms vs. 88±15 ms), PR interval (186±38 ms vs. 192±21 ms) and QRS+PR interval (283±48 ms vs. 280±39 ms) (p=ns for all).
Discussion
Findings:
Familial amyloidotic polyneuropathy is a multi-system disease which involves many organs with the heart commonly affected. In the present study, conventional LV structure measurements showed normal cavity size and systolic function in patients, including long axis function and SV, whereas wall thickness was significantly increased.
However, markers of LV dyssynchronous function clearly differentiated patients from controls, showing prolonged t-IVT and raised Tei index as well as high E/Em, the latter was consistent with high left atrial pressure. Only t-IVT correlated with HRV measurements, because of the significantly shortened relative LV filling time. Almost one third of our studied patients had reduced HRV. Although LV size and FS were preserved in this subgroup, long axis amplitude of motion was significantly reduced, t-IVT was longer, and Tei index and E/Em were both higher than in those with preserved HRV. QRS and PR interval were not different in the two subgroups of patients. Moreover, in patients with reduced HRV t-IVT correlated with the SV to a much stronger degree, as compared to in patients with preserved HRV. Finally, the incidence of cardiac events occurring in our patients was significantly higher in FAP with reduced HRV as compared o in those without. t
Data interpretation:
The most prominent finding in this study was the significant LV dyssynchronous function which correlated with markers of HRV, particularly in the subgroup of patients with reduced HRV. Also the same disturbances were the only ones profoundly found among patients who developed cardiac events as compared to those who did not. It is well documented that cardiac involvement in FAP is a recognized complication, with phenotypic picture of thickened walls and mainly reduced diastolic function [20] . This study is the first to demonstrate clear evidence for significant LV dyssynchrony in such patients, even in the absence of overt systolic dysfunction or electrical abnormalities. It was only the subgroup of patients with reduced HRV who, in addition, had reduced long axis function which represents subendocardial dysfunction, again despite having preserved overall systolic function. The strong association that we found between markers of ventricular dyssynchrony and stroke volume as well as the prevalence of cardiac events in patients with reduced HRV, suggest a serious clinical impact of those abnormalities rather than pure academic interest. These findings also demonstrate that in such patients with reduced HRV, the stroke volume has become dependent on the degree of LV dyssynchrony as shown by t-IVT, a pattern that is not physiological.
Indirect indices of raised left atrial pressure, i.e., E/Em, was higher in the patients' cohort as a whole. The same indices also differentiated the subgroups, being higher in patients with reduced HRV. T-IVT represents the time in the cardiac cycle when the LV is neither filling nor ejecting, generally caused by cavity dyssynchrony. These disturbances have been shown to have serious implications on overall ventricular performance, as they determine cardiac output [21] and exercise tolerance [22] in patients with heart failure. They have also been shown to determine clinical outcome in patients with systolic heart failure, in particular [23] . Our patients did not have significant evidence for systolic dysfunction, neither had clinical evidence for fluid retention. However, they had profound evidence for dyssynchronous LV with prolonged t-IVT and raised Tei index. Whether these disturbances represent a picture of diastolic heart failure, knowing that patients limited exercise tolerance perceived to be contributed to by other pathologies, this remains to be challenged. The further supportive evidence for severity of cardiac abnormalities was the association of those markers of dyssynchrony with RV and clinical outcome. H Despite the deeply rooted belief that autonomic nervous system abnormalities are the main cause for abnormal HRV in these patients, it seems that dyssynchronous LV function is another important factor. LV dyssynchrony limits filling time and hence stroke volume, thus is bound to dictate changes in heart rate, according to body needs.
An alternative argument could be that the autonomic disturbances themselves are the ones which dictate LV filling time and hence measurements of dyssynchrony. This is an unlikely explanation since our findings show an additional clear evidence for compromised LV subendocardial long axis function in patients with reduced HRV. This confirms the presence of intrinsic myocardial involvement with the amyloid pathology, despite being at a subendocardial level, and hence the dyssynchronous function, as reviously shown in other systemic diseases involving the myocardium [24] , [25] . p
Clinical implication:
Familial Amyloidotic Polyneuropathy patients have evidence for significant LV dyssynchrony, particularly those with reduced HRV. These findings may explain the failure of blood pressure response to fluid loading during general anaesthesia, known in these patients. A detailed preoperative assessment with view of cardiac resynchronization therapy ay improve clinical as well surgical outcome of these patients. m
Limitations:
Five of the 29 FAP patients were investigated after liver transplantation, but we did not subgroup these patients because of the small number. We did not have strain and strain rate measurements in these patients, which might have assisted in identifying segmental myocardial dysfunction of relevance [20] . All time measurements were corrected for R-R interval to eliminate any element of influence of heart rate on the accuracy of our data interpretation. Finally, we did not have myocardial biopsies which might have confirmed he pathological nature of the subendocardial abnormalities. t
Conclusion:
In familial amyloidosis with polyneuropathy, HRV correlates with markers of global left ventricular dyssynchrony. Such relationship is most powerful in patients with reduced HRV suggesting that dyssynchrony might hold an important role in controlling cardiac function and stroke volume. These findings should have significant clinical implications for optimum management of FAP patients, particularly those who may benefit from resynchronization therapy. Table 1 
